These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26938274)

  • 1. Exploiting the Chromone Scaffold for the Development of Inhibitors of Corticosteroid Biosynthesis.
    Gobbi S; Hu Q; Zimmer C; Engel M; Belluti F; Rampa A; Hartmann RW; Bisi A
    J Med Chem; 2016 Mar; 59(6):2468-77. PubMed ID: 26938274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of cytochromes P450 with xanthone-based molecules: from aromatase to aldosterone synthase and steroid 11β-hydroxylase inhibition.
    Gobbi S; Hu Q; Negri M; Zimmer C; Belluti F; Rampa A; Hartmann RW; Bisi A
    J Med Chem; 2013 Feb; 56(4):1723-9. PubMed ID: 23363058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of (pyridylmethylene)tetrahydronaphthalenes/-indanes and structurally modified derivatives: potent and selective inhibitors of aldosterone synthase.
    Ulmschneider S; Müller-Vieira U; Klein CD; Antes I; Lengauer T; Hartmann RW
    J Med Chem; 2005 Mar; 48(5):1563-75. PubMed ID: 15743198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of imidazolylmethylenetetrahydronaphthalenes and imidazolylmethyleneindanes: potent inhibitors of aldosterone synthase.
    Ulmschneider S; Müller-Vieira U; Mitrenga M; Hartmann RW; Oberwinkler-Marchais S; Klein CD; Bureik M; Bernhardt R; Antes I; Lengauer T
    J Med Chem; 2005 Mar; 48(6):1796-805. PubMed ID: 15771425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel pyridyl- or isoquinolinyl-substituted indolines and indoles as potent and selective aldosterone synthase inhibitors.
    Yin L; Hu Q; Emmerich J; Lo MM; Metzger E; Ali A; Hartmann RW
    J Med Chem; 2014 Jun; 57(12):5179-89. PubMed ID: 24899257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective dual inhibitors of CYP19 and CYP11B2: targeting cardiovascular diseases hiding in the shadow of breast cancer.
    Hu Q; Yin L; Hartmann RW
    J Med Chem; 2012 Aug; 55(16):7080-9. PubMed ID: 22861193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent 11β-hydroxylase inhibitors with inverse metabolic stability in human plasma and hepatic S9 fractions to promote wound healing.
    Zhu W; Hu Q; Hanke N; van Koppen CJ; Hartmann RW
    J Med Chem; 2014 Sep; 57(18):7811-7. PubMed ID: 25176013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heteroaryl-substituted naphthalenes and structurally modified derivatives: selective inhibitors of CYP11B2 for the treatment of congestive heart failure and myocardial fibrosis.
    Voets M; Antes I; Scherer C; Müller-Vieira U; Biemel K; Barassin C; Marchais-Oberwinkler S; Hartmann RW
    J Med Chem; 2005 Oct; 48(21):6632-42. PubMed ID: 16220979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly potent and selective nonsteroidal dual inhibitors of CYP17/CYP11B2 for the treatment of prostate cancer to reduce risks of cardiovascular diseases.
    Pinto-Bazurco Mendieta MA; Hu Q; Engel M; Hartmann RW
    J Med Chem; 2013 Aug; 56(15):6101-7. PubMed ID: 23859149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel pyridyl substituted 4,5-dihydro-[1,2,4]triazolo[4,3-a]quinolines as potent and selective aldosterone synthase inhibitors with improved in vitro metabolic stability.
    Hu Q; Yin L; Ali A; Cooke AJ; Bennett J; Ratcliffe P; Lo MM; Metzger E; Hoyt S; Hartmann RW
    J Med Chem; 2015 Mar; 58(5):2530-7. PubMed ID: 25711516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replacement of imidazolyl by pyridyl in biphenylmethylenes results in selective CYP17 and dual CYP17/CYP11B1 inhibitors for the treatment of prostate cancer.
    Hu Q; Jagusch C; Hille UE; Haupenthal J; Hartmann RW
    J Med Chem; 2010 Aug; 53(15):5749-58. PubMed ID: 20684610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-(Pyridin-3-yl)benzamides as selective inhibitors of human aldosterone synthase (CYP11B2).
    Zimmer C; Hafner M; Zender M; Ammann D; Hartmann RW; Vock CA
    Bioorg Med Chem Lett; 2011 Jan; 21(1):186-90. PubMed ID: 21129965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel imidazol-1-ylmethyl substituted 1,2,5,6-tetrahydropyrrolo[3,2,1-ij]quinolin-4-ones as potent and selective CYP11B1 inhibitors for the treatment of Cushing's syndrome.
    Yin L; Lucas S; Maurer F; Kazmaier U; Hu Q; Hartmann RW
    J Med Chem; 2012 Jul; 55(14):6629-33. PubMed ID: 22788843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and structure-activity relationships of azolylmethylpyrroloquinolines as nonsteroidal aromatase inhibitors.
    Ferlin MG; Carta D; Bortolozzi R; Ghodsi R; Chimento A; Pezzi V; Moro S; Hanke N; Hartmann RW; Basso G; Viola G
    J Med Chem; 2013 Oct; 56(19):7536-51. PubMed ID: 24025069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The adrenocortical tumor cell line NCI-H295R as an in vitro screening system for the evaluation of CYP11B2 (aldosterone synthase) and CYP11B1 (steroid-11beta-hydroxylase) inhibitors.
    Müller-Vieira U; Angotti M; Hartmann RW
    J Steroid Biochem Mol Biol; 2005 Aug; 96(3-4):259-70. PubMed ID: 15985365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of new 7-substituted-4-imidazolylmethyl coumarins and 4'-substituted-2-imidazolyl acetophenones open analogues as potent and selective inhibitors of steroid-11β-hydroxylase.
    Stefanachi A; Hanke N; Pisani L; Leonetti F; Nicolotti O; Catto M; Cellamare S; Hartmann RW; Carotti A
    Eur J Med Chem; 2015 Jan; 89():106-14. PubMed ID: 25462231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of annulated pyridines as inhibitors of aldosterone synthase (CYP11B2).
    Martin RE; Lehmann J; Alzieu T; Lenz M; Carnero Corrales MA; Aebi JD; Märki HP; Kuhn B; Amrein K; Mayweg AV; Britton R
    Org Biomol Chem; 2016 Jul; 14(25):5922-7. PubMed ID: 27245438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new class of nonsteroidal aromatase inhibitors: design and synthesis of chromone and xanthone derivatives and inhibition of the P450 enzymes aromatase and 17 alpha-hydroxylase/C17,20-lyase.
    Recanatini M; Bisi A; Cavalli A; Belluti F; Gobbi S; Rampa A; Valenti P; Palzer M; Palusczak A; Hartmann RW
    J Med Chem; 2001 Mar; 44(5):672-80. PubMed ID: 11262078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of 4-(4-nitro-2-phenethoxyphenyl)pyridine as a promising new lead for discovering inhibitors of both human and rat 11β-Hydroxylase.
    Hu Q; Kunde J; Hanke N; Hartmann RW
    Eur J Med Chem; 2015; 96():139-50. PubMed ID: 25874338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Steroidogenic Cytochromes P450 (CYPs) with 6-Substituted 1-Imidazolylmethylxanthones.
    Gobbi S; Hu Q; Zimmer C; Belluti F; Rampa A; Hartmann RW; Bisi A
    ChemMedChem; 2016 Aug; 11(16):1770-7. PubMed ID: 27071740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.